Trademark: 88056022
Word

Status
Registered
Status Code
700
Status Date
Tuesday, June 25, 2019
Serial Number
88056022
Registration Number
5789590
Registration Date
Tuesday, June 25, 2019
Mark Type
2
Filing Date
Friday, July 27, 2018
Published for Opposition
Tuesday, January 15, 2019

Trademark Owner History
Vertisis Custom Pharmacy - Original Registrant

Classifications
5 Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for chelation treatments; Medicinal preparations for promoting men's health, namely, treating erectile dysfunction, andropause, and male fertility, and performing testosterone replacement therapies; Medicinal preparations for promoting women's health, namely, treating menopause and female fertility; Medicinal preparations for hormone replacement therapy; Medicinal preparations for weight management; Medicinal preparations for prolotherapy treatments to treat inflammation, localized pain, generalized pain, and ligament laxity; Medicinal preparations for promoting animal health in the nature of infections, pain, inflammation, cancer, autoimmune disease, and ocular disease; Medicinal preparations for oncology treatments; Medicinal preparations for pain management; Prescription medicines, namely, intravenous pharmaceutical preparations for the treatment of cancer, cardiovascular disease, weight loss, diabetes, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Prescription medicines, namely, topical medications for the treatment of cancer, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain; Prescription medicines, namely, custom compounded medications for the treatment of cancer, cardiovascular disease, weight loss, diabetes, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Prescription medicines, namely, custom compounded medications for intravenous administration for the treatment of cancer, cardiovascular disease, weight loss, diabetes, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Prescription medicines, namely, custom compounded medications for topical administration for the treatment of cancer, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain; Prescription medicines, namely, custom compounded medications for nasal administration for weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, allergies, and neurotransmitter deficiencies; Medicinal preparations for the body to be applied in the form of intravenous fluids for the treatment of cancer, cardiovascular disease, weight loss, diabetes, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Medicinal preparations for the body to be applied in the form of topical ointments for the treatment of cancer, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain; Medicinal preparations for the body to be applied in the form of nasal sprays for weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, allergies, and neurotransmitter deficiencies; Custom compounded medicinal preparations for the body to be applied in the form of intravenous fluids for the treatment of cancer, cardiovascular disease, weight loss, diabetes, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Custom compounded medicinal preparations for the body to be applied in the form of topical ointments for the treatment of cancer, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain; Custom compounded medicinal preparations for the body to be applied in the form of nasal sprays for weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, allergies, and neurotransmitter deficiencies
The mark consists of a large equilateral triangle with one side of the triangle running horizontally, with a smaller equilateral triangle near the point of the triangle and a band running from the bottom side to the top side of the triangle parallel to the right side of the triangle. A second bar lies to the right of the triangle as a shadow of the large triangle.
Color is not claimed as a feature of the mark.

Trademark Events
Nov 16, 2018
Notification Of Examiners Amendment E-Mailed
Jul 31, 2018
New Application Entered
Aug 3, 2018
New Application Office Supplied Data Entered
Aug 4, 2018
Notice Of Design Search Code E-Mailed
Nov 14, 2018
Assigned To Examiner
Nov 16, 2018
Examiners Amendment -Written
Nov 16, 2018
Examiners Amendment E-Mailed
Nov 16, 2018
Examiner's Amendment Entered
Jan 15, 2019
Published For Opposition
Nov 16, 2018
Approved For Pub - Principal Register
Dec 6, 2018
Assigned To Lie
Dec 26, 2018
Notification Of Notice Of Publication E-Mailed
Jan 15, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2019
Noa E-Mailed - Sou Required From Applicant
May 7, 2019
Teas Statement Of Use Received
May 7, 2019
Use Amendment Filed
May 21, 2019
Case Assigned To Intent To Use Paralegal
May 23, 2019
Allowed Principal Register - Sou Accepted
May 24, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 25, 2019
Registered-Principal Register
May 22, 2019
Statement Of Use Processing Complete
Sep 10, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 10, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 12, 2021
Teas Change Of Correspondence Received
Aug 12, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 12, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
May 1, 2024
Teas Change Of Correspondence Received
Jun 25, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 1, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
May 1, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Trademark Alertz updated from USPTO on 2030-01-24